Brief: Nextcell Pharma Q4 Oper Loss Widens To SEK 8.6 Mln
27/10/2022 06:44
Oct 27 (Reuters) - NextCell Pharma AB NXTCL.ST :
* Q4 OPERATING INCOME SEK 1.4 MILLION VERSUS SEK 1.4 MILLION
YEAR
AGO
* Q4 OPERATING LOSS SEK 8.6 MILLION VERSUS LOSS SEK 4.5
MILLION
YEAR AGO
* BOARD OF DIRECTORS PROPOSES THAT NO DIVIDEND IS TO BE PAID
OF
FINANCIAL YEAR
Source text for Eikon: ID:nWkrb1wWZy
Further company coverage: NXTCL.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on NextCell Pharma AB
See all newsBrief: NextCell Pharma Q1 Operating Income At SEK 2.8 Million
Brief: Nextcell Pharma Q4 Operating Income SEK 1.8 Mln
Brief: Nextcell Pharma Says ProTrans Data Show Insulin Production Preservation
Brief: NextCell Board Proposes Directed Issue Of 15,000,000 Shares
Brief: Nextcell Decides To Propose Directed Share Issue Of SEK 15 Mln